Regulatory considerations for vaccine development, talk 2 clinical regulatory considerations (part 2 of 2) /
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Video |
Language: | English |
Published: |
London :
Henry Stewart Talks,
2015.
|
Series: | Henry Stewart talks. Biomedical & life sciences collection. Vaccines.
|
Subjects: | |
Online Access: | https://hstalks.com/bs/3170/ Series |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000ngm a2200000 a 4500 | ||
---|---|---|---|
001 | HST4161 | ||
003 | UkLoHST | ||
006 | m c | ||
007 | cr|cna|||a|||| | ||
007 | vz|czazum | ||
008 | 151211s2015 enk|||||||||||s|||v|eng d | ||
028 | 5 | 0 | |a 4161 |b Henry Stewart Talks |
035 | |a (UkLoHST)3170 | ||
040 | |a UkLoHST |b eng |c UkLoHST | ||
100 | 1 | |a Schrager, Lewis K., |u (Aeras, USA) |4 spk |9 100421 | |
245 | 1 | 0 | |a Regulatory considerations for vaccine development, talk 2 |h [electronic resource] : |b clinical regulatory considerations (part 2 of 2) / |c Lewis K. Schrager. |
246 | 3 | |a Clinical regulatory considerations. Part 2 | |
260 | |a London : |b Henry Stewart Talks, |c 2015. | ||
300 | |a 1 online resource (1 streaming video file (35 min.) : |b color, sound). | ||
490 | 1 | |a Vaccines : principles, recent developments and future directions, |x 2056-452X | |
500 | |a Animated audio-visual presentation with synchronized narration. | ||
500 | |a Title from title frames. | ||
505 | 0 | |a Contents: Biological License Application (BLA) pathways -- Traditional, accelerated approval, "Animal Rule" -- Programs that accelerate the clinical testing (IND) and review (BLA) processes -- Fast track designation -- Breakthrough designation -- Priority review -- The package insert -- Pediatric study requirements -- Adjuvants -- Adaptive trial design from a regulatory perspective -- Developing vaccines for global infectious diseases. | |
506 | |a Access restricted to subscribers. | ||
538 | |a Mode of access: World Wide Web. | ||
610 | 1 | 0 | |a United States. |b Food and Drug Administration. |9 100422 |
650 | 0 | |a Vaccines industry |x Government policy |z United States. |9 100423 | |
650 | 0 | |a Vaccines |x Development. |9 100424 | |
650 | 2 | |a Animal Testing Alternatives. |9 100425 | |
650 | 2 | |a Biological Products |x standards. |9 100426 | |
650 | 2 | |a Clinical Trials as Topic |x legislation & jurisprudence. |9 100427 | |
650 | 2 | |a Drug Approval |x methods. |9 100428 | |
650 | 2 | |a Drug Evaluation, Preclinical. |9 100429 | |
650 | 2 | |a Drug Industry |x legislation & jurisprudence. |9 100430 | |
650 | 2 | |a Investigational New Drug Application |x legislation & jurisprudence. |9 100431 | |
650 | 2 | |a Investigational New Drug Application |x methods. |9 100432 | |
650 | 2 | |a United States Food and Drug Administration |x legislation & jurisprudence. |9 100433 | |
650 | 2 | |a United States Food and Drug Administration |x standards. |9 100434 | |
650 | 2 | |a Vaccines |x standards. |9 100435 | |
830 | 0 | |a Henry Stewart talks. |p Biomedical & life sciences collection. |p Vaccines. |9 100436 | |
856 | 4 | 0 | |u https://hstalks.com/bs/3170/ |
856 | 4 | 2 | |u https://hstalks.com/bs/p/923/ |3 Series |
999 | |c 214835 |d 214834 |